000 01278 a2200349 4500
005 20250518090344.0
264 0 _c20210308
008 202103s 0 0 eng d
022 _a1664-3224
024 7 _a10.3389/fimmu.2020.00139
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRolfe, Barbara E
245 0 0 _aEditorial: The Role of Complement in Tumors.
_h[electronic resource]
260 _bFrontiers in immunology
_c2020
300 _a139 p.
_bdigital
500 _aPublication Type: Editorial; Introductory Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aComplement Activation
_xdrug effects
650 0 4 _aComplement System Proteins
_ximmunology
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aHumans
650 0 4 _aImmune Checkpoint Inhibitors
_xpharmacology
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aNeoplasms
_xdrug therapy
700 1 _aPio, Ruben
700 1 _aWoodruff, Trent M
700 1 _aMarkiewski, Maciej M
700 1 _aManthey, Helga D
773 0 _tFrontiers in immunology
_gvol. 11
_gp. 139
856 4 0 _uhttps://doi.org/10.3389/fimmu.2020.00139
_zAvailable from publisher's website
999 _c30691635
_d30691635